SBIR/STTR Research Award

A nanosized magnetic particle system for fast and efficient neuronal extracellular vesicle enrichment from plasma

Award identifier e845346deb5cd374017703e99e5b09e49856aa2a8867b553a72d05a988193c83Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$306,509

Program and phase

SBIR · Phase I

Award year

2023

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CAPTIS DIAGNOSTICS
Proposal award date
2023-09-18
Contract end date
2024-08-31
UEI
JS3HJ4EHJ9J8
Solicitation number
PA22-176
Topic code
R

Research abstract

SUMMARY/Abstract Extracellular vesicles (EVs) are nanovesicles, which contain surface markers, and cell- and cell-state-specific cargo of their tissue (and cell) of origin, reflecting the tissue or cell’s physiological state. Most importantly, neuronal EVs can pass the blood-brain barrier (BBB) into blood circulation and provide a new approach of gaining direct access to brain pathogenic processes. Emerging clinical studies show that neuronal EVs in blood carry pathogenic biomarkers that can detect and predict neurological diseases such as, Alzheimer’s disease, Parkinson disease, amyotrophic lateral sclerosis, and traumatic brain injury, etc. Therefore, enrichment of neuronal EVs from peripheral blood provides a minimally invasive way to sample components of brain tissue for neurological diseases. To unleash neuronal EVs’ great potential in neurological diseases diagnosis applications, rapid and efficient enrichment of neuronal EVs from blood plasma is a prerequisite. However, there is major challenge to efficiently isolate neuronal EVs from blood plasma, and there are no commercially available technologies/kits for the isolation of neuronal EVs from blood plasma. Herein, we propose to develop a neuronal EVs nanoprobes (neuron-NPs) technology for high-yield isolation of neuronal EV directly from plasma sample as a research use only kit. We will develop and optimize these neuron- NPs for rapid and efficient magnetic isolation of neuronal EVs in a buffer system (Aim 1). The Aim 2 will perform analytical validation of neuron-NP technology in plasma samples. Successful completion of these Aims will yield an advanced proprietary technology platform for neuronal EVs isolations in basic and clinical research for various neurological diseases. Phase II activities will be focused on scaling up the manufacturing of neuronal EVs nanoprobes kit and developing high-throughput automatic sample processing system integrated with neuron- NPs kit.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

6 SBIR/STTR records share this UEI (2018–2025). Reported award amounts total $2,795,515. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.